Cancer-related Mutations with Local or Long-range Effects on an Allosteric Loop of p53

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 5,51 MB, PDF-dokument

The tumor protein 53 (p53) is involved in transcription-dependent and independent processes. Several p53 variants related to cancer have been found to impact protein stability. Other variants, on the contrary, might have little impact on structural stability and have local or long-range effects on the p53 interactome. Our group previously identified a loop in the DNA binding domain (DBD) of p53 (residues 207–213) which can recruit different interactors. Experimental structures of p53 in complex with other proteins strengthen the importance of this interface for protein–protein interactions. We here characterized with structure-based approaches somatic and germline variants of p53 which could have a marginal effect in terms of stability and act locally or allosterically on the region 207–213 with consequences on the cytosolic functions of this protein. To this goal, we studied 1132 variants in the p53 DBD with structure-based approaches, accounting also for protein dynamics. We focused on variants predicted with marginal effects on structural stability. We then investigated each of these variants for their impact on DNA binding, dimerization of the p53 DBD, and intramolecular contacts with the 207–213 region. Furthermore, we identified variants that could modulate long-range the conformation of the region 207–213 using a coarse-grain model for allostery and all-atom molecular dynamics simulations. Our predictions have been further validated using enhanced sampling methods for 15 variants. The methodologies used in this study could be more broadly applied to other p53 variants or cases where conformational changes of loop regions are essential in the function of disease-related proteins.

OriginalsprogEngelsk
Artikelnummer167663
TidsskriftJournal of Molecular Biology
Vol/bind434
Udgave nummer17
Antal sider33
ISSN0022-2836
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
The result of this research has been achieved using the DECI-PRACE 16th HPC Grants on Archer2. The research has been also carried out thanks to the access to the Danish HPC Infrastructure Computerome2. The research has been supported by grants from LEO Foundation (LF17006), Danmarks Grundforskningsfond (DNRF125), Hartmann Foundation (A33877), Danish Cancer Society (R-257-A14720), and the Danish Childhood Cancer Foundation (2019-5934 and 2020-5769). This work is part of Interregional Childhood Oncology Precision Medicine Exploration, across Oresund collaboration between University Hospital Copenhagen, Rigshospitalet, Lund University, RegionSkåne, and Technical University Denmark, supported by the European Regional Development Fund. This work is also part of the nationwide research program Childhood Oncology Network Targeting Research, Organisation & Life expectancy (CONTROL).

Publisher Copyright:
© 2022 The Author(s)

ID: 329574163